Aktiesnakken — Maj 2010
-
står da i Q1
-
-
søg i PDF filen, på sydkorea
-
og Høiberg mener at US patent kommer også
-
Der mener jeg måske at BioPorto burde have meddelt særskilt, at Sydkorea havde godkendt NGAL patentet
-
mange tak, regner med du mener med Pingu:)
-
mon ikke, vi skal da ikke handle under 7
-
finanstilsynet har undladt at undersøge Saxobank
-
ifølge radioavisen. De kører altså hårdt på dem.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind